10 February 2006 Mechanisms of low level light therapy
Michael R. Hamblin, Tatiana N Demidova
Author Affiliations +
Proceedings Volume 6140, Mechanisms for Low-Light Therapy; 614001 (2006)
Event: SPIE BiOS, 2006, San Jose, California, United States
The use of low levels of visible or near infrared light for reducing pain, inflammation and edema, promoting healing of wounds, deeper tissues and nerves, and preventing tissue damage has been known for almost forty years since the invention of lasers. Originally thought to be a peculiar property of laser light (soft or cold lasers), the subject has now broadened to include photobiomodulation and photobiostimulation using non-coherent light. Despite many reports of positive findings from experiments conducted in vitro, in animal models and in randomized controlled clinical trials, LLLT remains controversial. This likely is due to two main reasons; firstly the biochemical mechanisms underlying the positive effects are incompletely understood, and secondly the complexity of rationally choosing amongst a large number of illumination parameters such as wavelength, fluence, power density, pulse structure and treatment timing has led to the publication of a number of negative studies as well as many positive ones. In particular a biphasic dose response has been frequently observed where low levels of light have a much better effect than higher levels. This introductory review will cover some of the proposed cellular chromophores responsible for the effect of visible light on mammalian cells, including cytochrome c oxidase (with absorption peaks in the near infrared) and photoactive porphyrins. Mitochondria are thought to be a likely site for the initial effects of light, leading to increased ATP production, modulation of reactive oxygen species and induction of transcription factors. These effects in turn lead to increased cell proliferation and migration (particularly by fibroblasts), modulation in levels of cytokines, growth factors and inflammatory mediators, and increased tissue oxygenation. The results of these biochemical and cellular changes in animals and patients include such benefits as increased healing in chronic wounds, improvements in sports injuries and carpal tunnel syndrome, pain reduction in arthritis and neuropathies, and amelioration of damage after heart attacks, stroke, nerve injury and retinal toxicity.
© (2006) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Michael R. Hamblin and Tatiana N Demidova "Mechanisms of low level light therapy", Proc. SPIE 6140, Mechanisms for Low-Light Therapy, 614001 (10 February 2006); Logo
Cited by 265 scholarly publications and 20 patents.
Get copyright permission  Get copyright permission on Copyright Marketplace

Wound healing


Acquisition tracking and pointing

Laser therapeutics

Light emitting diodes



Tissue regeneration with photobiomodulation
Proceedings of SPIE (March 08 2013)
Photobiomodulation (PBM) with 20 W at 640 nm pre...
Proceedings of SPIE (February 17 2017)
Photobiomodulation on sports injuries
Proceedings of SPIE (December 08 2003)
Cellular mechanisms of low-power laser therapy
Proceedings of SPIE (September 22 2003)

Back to Top